Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAX8 | Q06710 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9504057 | 1.00 | PAX8 (0.44) | PAX8 | |
| SCHEMBL3899055 | 1.00 | PAX8 (0.44) | PAX8 | |
| SCHEMBL3158180 | 1.00 | PAX8 (0.44) | PAX8 | |
| SCHEMBL9504052 | 1.00 | PAX8 (0.44) | PAX8 | |
| SCHEMBL29425221 | 1.00 | PAX8 (0.44) | PAX8 | |
| SCHEMBL489573 | 1.00 | PAX8 (0.44) | PAX8 | |
| SCHEMBL476387 | 1.00 | PAX8 (0.44) | PAX8 | |
| Hydrochloric Acid SCHEMBL1722152 | 0.97 | PAX8 (0.43) | PAX8 | |
| SCHEMBL14151119 | 0.97 | PAX8 (0.43) | PAX8 | |
| SCHEMBL11403360 | 0.97 | PAX8 (0.43) | PAX8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | JIANGNAN UNIVERSITY (CN) | 2025-09-11 | — | — | US | claimed |
| EP-4243863-A2 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | Pfizer Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| WO-2022101745-A2 | IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF | PFIZER INC. (US) | 2022-05-19 | — | — | WO | claimed |
| US-10851130-B2 | Chemical synthesis method of Plesiomonas shigelloides serotype O51 O-antigen oligosaccharide | JIANGNAN UNIVERSITY (CN) | 2020-12-01 | — | — | US | claimed |
| US-20190233459-A1 | Chemical Synthesis Method of Plesiomonas Shigelloides Serotype O51 O-antigen Oligosaccharide | JIANGNAN UNIVERSITY (CN) | 2019-08-01 | — | — | US | claimed |
| EP-0320960-B1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1993-05-12 | — | — | EP | claimed |
| US-5145848-A | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1992-09-08 | — | — | US | claimed |
| EP-0396588-A1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1990-11-14 | — | — | EP | claimed |
| WO-1989005815-A1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1989-06-29 | — | — | WO | claimed |
| EP-0320960-A1 | Amino anthracenediones-bis platinum complexes, useful as antitumoral agents | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1989-06-21 | — | — | EP | claimed |
| EP-4729073-A1 | SYNTHETIC VACCINES AGAINST FRANCISELLA TULARENSIS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-04-22 | — | — | EP | disclosed |
| US-20250282810-A1 | Chemical Synthesis Method and Application of V. Cholerae Serotype O100 O-Antigen Oligosaccharides | JIANGNAN UNIVERSITY (CN) | 2025-09-11 | — | — | US | disclosed |
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | JIANGNAN UNIVERSITY (CN) | 2025-09-11 | — | — | US | disclosed |
| US-20240189797-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE BINDING DOMAIN CONTAINING MOLECULES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-06-13 | — | — | US | disclosed |
| US-20240124911-A1 | ENZYMATIC METHOD FOR PREPARATION OF GDP-FUCOSE | MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V. (DE) | 2024-04-18 | — | — | US | disclosed |
| WO-1989005815-A1 | AMINO ANTHRACENEDIONES-BIS PLATINUM COMPLEXES, USEFUL AS ANTITUMORAL AGENTS | BOEHRINGER BIOCHEMIA ROBIN S.P.A. (IT) | 1989-06-29 | — | — | WO | disclosed |
| EP-0320960-A1 | Amino anthracenediones-bis platinum complexes, useful as antitumoral agents | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1989-06-21 | — | — | EP | disclosed |
| US-4831126-A | Antigenic polysaccharide specific to Brucella abortus and Yersinia enterocolitica serotype 0:9 | CANADIAN PATENTS & DEVELOPMENT LTD. (CA) | 1989-05-16 | — | — | US | disclosed |
| EP-0015468-B1 | 6-DEOXYGLUCOSAMINE-PEPTIDE DERIVATIVES, THEIR PRODUCTION AND USE | Takeda Chemical Industries, Ltd. (JP) | 1982-12-29 | — | — | EP | disclosed |
| EP-0015468-A1 | 6-Deoxyglucosamine-peptide derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1980-09-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250282810-A1 | Chemical Synthesis Method and Application of V. Cholerae Serotype O100 O-Antigen Oligosaccharides | DDOST, OGA, DAD1 | PAX8 4329/4885 |
| US-20240189797-A1 | SEPARATION MEDIA AND PURIFICATION METHODS FOR CARBOHYDRATE BINDING DOMAIN CONTAINING MOLECULES | CACYBP, MGAM, MASP2 | PAX8 3552/4885 |
| US-20250282806-A1 | CHEMICAL SYNTHESIS METHOD FOR DISACCHARIDE FRAGMENT OF VIBRIO VULNIFICUS BIOTYPE 2 SEROVAR A O-ANTIGEN | OGA, DDOST, FUT6 | PAX8 4383/4885 |
| US-20190233459-A1 | Chemical Synthesis Method of Plesiomonas Shigelloides Serotype O51 O-antigen Oligosaccharide | DDOST, OSTC, OGA | PAX8 2400/4885 |
| US-10851130-B2 | Chemical synthesis method of Plesiomonas shigelloides serotype O51 O-antigen oligosaccharide | DDOST, OSTC, OGA | PAX8 2400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.